The decellularized porcine heart valve matrix in tissue engineering Platelet adhesion and activation
Marie-Theres Kasimir1 , Guenter Weigel 1 , Jyotindra Sharma1 , Erwin Rieder2 , Gernot Seebacher1 , Ernst Wolner1 , Paul Simon 1
1 Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria 2 Department of Surgery, Medical University of Vienna, Vienna, Austria
Summary
An approach in tissue engineering of heart valves is the use of
decellularized xenogeneic matrices to avoid immune response
after implantation.The decellularization process must preserve
the structural components of the extracellular matrix to
provide a biomechanically stable scaffold. However, it is known
that in vascular lesions platelet adhesion to extracellular matrix
components occurs and platelet activation is induced. In the
present study we examined the effects of a decellularized porcine
heart valve matrix on thrombocyte activation and the influence
of re-endothelialisation in vitro. Porcine pulmonary conduits
were decellularized using Triton X-100, Na-deoxycholate
and Igepal CA-630 ® followed by a ribonuclease digestion.
Cryostat sections of decellularized heart valves with and without
seeding with human umbilical vein endothelial cells
(HUVEC) were incubated with platelet rich plasma. Samples
were either stained with fluorescent antibodies for CD41 and
PAC-1 (recognizing the activated fibrinogen receptor) or fixed
with glutaraldehyde.Thereafter, the samples were processed for
laser scanning microscopy (LSM) or scanning electron microscopy
(SEM). Examination by LSM showed numerous platelets
with co-localized staining for CD41 and PAC-1 on the nonseeded
decellularized heart valve matrix whereas after seeding
with endothelial cells no platelet activation was detected. SEM
revealed platelet adhesion and aggregate formation only on the
surface of the non-seeded or partially denuded matrix specimens.
We show in this study that the decellularized porcine matrix
acts as a platelet-activating surface. Seeding with endothelial
cells effectively abolishes the platelet adhesion and activation
and therefore is necessary to eliminate thrombogenicity in tissue
engineered heart valves.
DOI
10.1160/TH05-01-0025